A positive centromere antibody test means your immune system is making antibodies against part of your own cells. Doctors take that seriously, but it is not a diagnosis on its own. The result is most closely linked to a milder, slow-moving form of scleroderma, a condition that thickens the skin and can affect blood vessels. It can also show up with certain liver and dry-eye-and-mouth conditions, or in people who stay well, so what it means for you depends on your symptoms.
What the Test Actually Detects
Every cell’s chromosomes have a pinched middle section called the centromere. Centromere antibodies attack proteins there, and the main target is one called CENP-B, which is why most labs measure it.1Healthmatters.io. CENP-B Antibody Positive: What It Means, Symptoms & Next Steps – Systemic Sclerosis Your report may say “anti-centromere antibody,” “ACA,” or “anti-CENP-B.” These describe the same finding.2Journal of Molecular Pathology. Clinical and Molecular Features of Anti-CENP-B Autoantibodies
The antibody often appears first on an ANA test, where the lab sees a “centromere pattern” of evenly scattered dots, sometimes coded AC-3.3PubMed. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario A follow-up test for CENP-B antibody agrees with that pattern more than 99% of the time.4PubMed Central. Assessing the concordance between centromere AC-3 immunofluorescence pattern and anti-centromere protein-B antibody, and analyzing clinical correlates of dual positivity: A retrospective study
The two tests work differently, which is why you may see two lines about one antibody. The ANA is a screen. The lab applies your blood to cells on a slide and a technician looks under a microscope for glowing patterns, so the centromere pattern is something a person sees, not a number a machine measures. The CENP-B test measures the amount of antibody directly, usually as a number with a positive or negative flag. It is also more specific, because it names the exact protein being targeted instead of describing how the cells glow.
A titer such as 1:640 is a dilution: the higher the second number, the more antibody was found. Numeric CENP-B results come with the lab’s own cutoff printed beside them. It is fair to ask your doctor whether your result was a screening pattern, a specific test, or both.
Doctors order the test for several reasons: fingers turning white or blue in the cold, tight finger skin, heartburn or trouble swallowing, or abnormal liver blood tests. Sometimes it turns up on a broad ANA panel run for fatigue or joint pain.
The Strong Link to Limited Scleroderma
Limited scleroderma, once called CREST, combines calcium lumps under the skin, Raynaud’s phenomenon, a sluggish food pipe, tight finger skin, and small red spots that are visible blood vessels.5PubMed. The CREST syndrome: a distinct serologic entity with anticentromere antibodies Raynaud’s means fingers or toes turn white, then blue, then red with cold or stress. Nearly everyone with CREST in one early group, 26 of 27, carried high levels of this antibody.6PubMed. The CREST syndrome: a distinct serologic entity with anticentromere antibodies
Only about a third of all scleroderma patients test positive, rising to over half of those with the limited form.7PubMed. Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies But when the test is positive, it points toward scleroderma rather than other conditions more than 97% of the time in scleroderma clinics.8PubMed. Anticentromere-A and Anticentromere-B Antibodies Show High Concordance and Similar Clinical Associations in Patients with Systemic Sclerosis People with the antibody also more often have red finger spots (93% vs 75%) and calcium deposits (55% vs 22%).9PubMed. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis
The 97% figure comes from scleroderma clinics. Among people tested for many reasons across a wider pool, far more positives come from other settings, so the same result carries less weight than it does in a scleroderma clinic.
In one group of people who tested positive, only about 11% had limited scleroderma, while many had other rheumatic or nonrheumatic conditions.10PubMed. Clinical correlation of anticentromere antibodies Diagnosis rests on a set of signs, not one blood result, and many people are positive years before any sign appears, or never develop one.
Doctors weigh the antibody together with Raynaud’s, skin changes, nail-fold findings and swallowing problems. Some people with a positive result have only Raynaud’s for years, which doctors sometimes describe as an early or incomplete picture. Things worth mentioning to your doctor include color changes in the fingers with cold, painful sores on fingertips, tight, shiny or puffy finger skin, heartburn or food sticking when you swallow, and small red dots on your hands, face or lips.
If You Have Raynaud’s and a Positive Result
Doctors recommend this test for everyone with Raynaud’s.11PubMed. The anticentromere antibody: disease specificity and clinical significance In people with Raynaud’s, having centromere or related antibodies made later connective tissue disease far more likely, about 63 times.12PubMed. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud’s disease. A prospective study It predicted the red skin spots in particular.13PubMed. Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud’s disease. A prospective study
“Very early” scleroderma usually means Raynaud’s plus a positive antibody, without skin thickening yet. Doctors may look at the tiny blood vessels in the nail folds with a magnifier, and changes there plus the antibody strengthen the warning. Many people in this stage progress slowly, over years.
People with very early scleroderma had lower antibody levels than those with established disease.14PubMed Central. Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis Levels then stay fairly steady for years and don’t track how the disease changes.15PubMed. A long-term longitudinal study of anticentromere antibodies Repeat tests rarely add much, so follow-up focuses on your symptoms. Plain Raynaud’s without antibodies is common and usually harmless. An autoimmune antibody shifts it toward watchful follow-up.
Can the Result Be Wrong or Mean Nothing
Fewer than 1% of healthy people without autoimmune disease test positive.16Instalab. Centromere B Antibody Test Low-level results more often appear in other autoimmune conditions or in healthy people.17Testing.com. Anti-Centromere Antibody Test
Labs can also err. One machine-read CENP-B blood test method gave a possible false positive in about 1 in 5 positives compared with the microscope pattern.18PubMed. Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen Unusual blood proteins, such as in some multiple myeloma samples, can cause false positives on these tests too.19Arthritis & Rheumatism. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities: I. Precision, sensitivity, and specificity A strong result confirmed by two methods is more trustworthy than a single low one.
A result just above the lab’s cutoff is a weaker signal than a very high one, and many labs print the cutoff so you can see the gap. A low positive with no symptoms is often handled with a symptom review and a plan to recheck if something changes, rather than extensive testing. Because it can come from another autoimmune condition, doctors may look at the rest of your antibody results and symptoms before drawing conclusions.
If your result is borderline, you can ask:
- Was it confirmed by both the pattern and a specific test?
- How far above the cutoff was it?
- Would repeating it with another method help?
- Do any of my symptoms fit?
How Serious It Is If You Do Have Scleroderma
In people with this antibody and scleroderma, about 96% were alive at 5 years and 85% at 10 years with the limited form.20PubMed Central. Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis Those with diffuse scleroderma without the antibody fared worse, at 72% at 10 years.21PubMed Central. Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis These figures come from groups of patients followed over many years, so they describe averages and cannot predict one person’s course. Many of those patients were treated in earlier decades, and monitoring and treatment have since improved.
The antibody goes with less lung scarring and less kidney crisis.22Rheumatology. 059. THE DISTINCTIVE CLINICAL PHENOTYPE OF ANTI-CENTROMERE ANTIBODY–POSITIVE DIFFUSE SYSTEMIC SCLEROSIS In one Japanese group, all centromere-positive people with kidney crisis survived the first year.23Annals of the Rheumatic Diseases. The association of autoantibodies with morbidity and mortality of scleroderma renal crisis in Japan Lower risk is not zero risk, though, so doctors still check for these problems when symptoms suggest them. Limited scleroderma can also cause ongoing trouble such as reflux, swallowing difficulty and finger sores, which affect daily life even when organ risk is low.
The main concern is pulmonary arterial hypertension, or high blood pressure in the lungs, which occurs in about 15% of scleroderma patients.24PubMed. Impact of anti-centromere antibodies on pulmonary function test results in patients with systemic sclerosis without established or suspected pulmonary disease About 17% of centromere-positive scleroderma patients developed it in one group.25Immuno. Possible Protective Effect of Immunomodulatory Therapy on Development of Pulmonary Hypertension in Centromere Positive Systemic Sclerosis So anyone positive with scleroderma should have routine screening for it.26PubMed Central. Limited Scleroderma-Induced Pulmonary Arterial Hypertension Resulting in Impaired Postoperative Respiratory Function Immune-calming treatment before it appeared was linked to lower risk.27Immuno. Possible Protective Effect of Immunomodulatory Therapy on Development of Pulmonary Hypertension in Centromere Positive Systemic Sclerosis
This condition can develop quietly, sometimes years after skin symptoms begin. Screening usually means a yearly heart ultrasound and breathing tests that measure how well oxygen passes into the blood. Sometimes a blood marker of heart strain is added. Abnormal results may lead to a right-heart catheter test.
Warning signs include new or worsening breathlessness climbing stairs, fatigue, fainting, chest discomfort, and swollen ankles. Report these promptly rather than waiting for the next check-up.
Liver Disease and Sjögren’s
Primary biliary cholangitis (PBC) is an autoimmune disease that slowly damages the small bile ducts in the liver. A positive centromere result alongside abnormal liver tests raises suspicion of PBC, which doctors confirm with further tests.28American Journal of Gastroenterology. S2593 Primary Biliary Cholangitis Unveiled by Positive Anti-centromere Antibodies PBC often comes to light through a routine blood test showing abnormal liver values, sometimes in people who feel completely well. When symptoms do occur, the common ones are fatigue and itching, which are easy to blame on other causes.
If liver disease is suspected, expect liver enzymes, especially alkaline phosphatase, and an anti-mitochondrial antibody test for PBC. A liver ultrasound or scarring scan may follow. PBC is treatable with a daily medicine that slows it.
In PBC, the antibody is linked to higher risk of swollen veins in the food pipe and bleeding from them.29PubMed. The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: Enhancing the prognostic utility on the GLOBE scoring system It raised the odds of those veins about 3.5-fold.30PubMed Central. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset? These veins swell when pressure builds in the liver’s blood supply, usually with more advanced scarring. Most people with PBC and the antibody do not have bleeding, and doctors check for them when liver findings suggest it.
The antibody is also tied to Sjögren’s syndrome, which causes dry eyes and mouth. About 13% of people with Sjögren’s carry it.31PubMed. Anti-centromere antibody-positive Sjögren’s syndrome: A distinct clinical subgroup? They more often have Raynaud’s, tight finger skin and thyroid problems.32PubMed. Anti-centromere antibody-positive Sjögren’s syndrome: A distinct clinical subgroup? Their salivary glands show more changes on ultrasound.33PubMed Central. Anti-centromere antibody positivity is an independent variable associated with salivary gland ultrasonography score in Sjögren’s syndrome
What Happens After a Positive Result
Expect a referral to a rheumatologist, who will examine your skin, fingers and nail folds. Baseline heart and breathing tests are common because of the lung blood-pressure link.34PubMed Central. Limited Scleroderma-Induced Pulmonary Arterial Hypertension Resulting in Impaired Postoperative Respiratory Function Liver tests are worth checking given the PBC link.35PubMed. The anticentromere antibody: disease specificity and clinical significance
The rheumatologist may add blood tests for other autoimmune antibodies, blood counts and kidney function to see the wider picture. A quick look at the tiny vessels at the base of the fingernail under magnification, is painless and often done in the office. If you have swallowing symptoms, the doctor may ask about reflux treatment or further evaluation of the food pipe.
To prepare, photograph your finger color changes during an attack, list any swallowing, heartburn, dryness and breathing symptoms, bring all prior lab reports, and note any family history of autoimmune disease.
If you have a positive result but no diagnosis, follow-up is often yearly with a symptom check. Keep your hands warm, avoid smoking, and report new symptoms rather than waiting. If disease is diagnosed, treatment targets symptoms such as Raynaud’s or reflux, and immune-calming medicines may be used.
Fertility and Pregnancy
In IVF, women with this antibody had fewer embryos develop well, about 23% reaching day 5 versus about 42% in others.36Fertility and Sterility. Impact of anti-centromere antibodies on early embryonic development Implantation and pregnancy rates were lower, though miscarriage was not higher.37PubMed Central. Pregnancy outcomes of patients with positive anticentromere antibodies receiving in vitro fertilization-embryo transfer Once pregnant, birth weight, prematurity and birth defects were no different.38Human Reproduction. P-766 Birth outcomes in Anti-centromere antibody (ACA) -positive patients treated with ART These studies looked at women already in fertility treatment, who are not typical of all women with the antibody, so the results may not apply to someone conceiving naturally.
If you’re planning a pregnancy, tell your fertility doctor about the result. Scleroderma with high blood pressure in the lungs needs specialist pregnancy planning. Most positive women without organ disease have normal pregnancies.